Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

Background Coronavirus disease 2019 (COVID-19), caused by a novel corinavirus (later named SARS-CoV-2 virus), was fistly reported in Wuhan, Hubei Province, China towards the end of 2019. Large-scale spread within China and internationally led the World Health Organization to declare a Public Health...

Full description

Bibliographic Details
Main Authors:	Monaghan, K, Wang, Y, Zhou, F, Zhang, D, Zhao, J, Du, R, Hu, Y, Cheng, Z, Gao, L, Jin, Y, Luo, G, Fu, S, Lu, Q, Du, G, Wang, K, Lu, Y, Fan, G, Zhang, Y, Liu, Y, Ruan, S, Liu, W, Jaki. T, Hayden, FG, Horby, PW, Cao, B, Wang, C
Format:	Journal article
Language:	English
Published:	BioMed Central 2020

Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

Similar Items